Volume : 12, Issue : 06, June – 2025
Title:
PREGNANCY INDUCED HYPERTENSION: A META ANALYSIS OF PREVALENCE, RISK FACTORS, CO-MORBIDITIES MATERNAL COMPLICATIONS AND TREATMENT
Authors :
Mrs.Musarrath Mubeen*,Dr.T.Mangilal,B.Venkatesh, M.Hansika, G.Sravanthi, M.Nandhini, B.Nithin Rao
Abstract :
Pregnancy-Induced Hypertension (PIH) remains a significant cause of maternal and perinatal morbidity and mortality worldwide. Despite numerous individual studies, wide variability exists in reported prevalence, associated risk factors, complications, and management strategies. This meta-analysis aims to synthesize current evidence to provide a comprehensive overview of prevalence,risk factors,co-morbidities and maternal complications related to PIH.
A systematic review and meta-analysis were conducted using data from peer-reviewed articles published between 2020–2024. Databases including PubMed, Web of Science, and Google Scholar were searched using defined keywords. Eligible studies reported on the prevalence, risk factors, complications, or treatment of PIH. Data were extracted and pooled.
A total of 14 studies comprising 16649 pregnant women were included. The pooled global prevalence of PIH was estimated in the age between 30-40. Significant risk factors identified and included Obesity is the major risk factor followed by pre-eclampsia, Chronic Hypertension and Nulliparity.
Diabetes Mellitus is the most common co-morbidity, kidney Diseases are the second most prevalent. Placental Abruption was the most prevalent maternal complication. Among treatment options, antihypertensive medications Labetalol, Nifedipine were significant monotherapy choice. Future research should focus on context-specific interventions and long-term follow-up of affected mothers and neonates.
Keywords: Pregnancy-induced hypertension, prevalence, risk factors, complications, treatment, meta-analysis.
Cite This Article:
Please cite this article in press Musarrath Mubeen et al., Pregnancy Induced Hypertension: A Meta Analysis Of Prevalence, Risk Factors, Co-Morbidities Maternal Complications And Treatment.., Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1.T firoz, LA Magee et. al. 2014 Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
2.Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S. 2010 Management of hypertensive disorders during pregnancy, summary of NICE guidance. BMJ 341: c2207.
3.Tilahun Mekonnen Regassa et al. 2012 Pregnancy Induced Hypertension and Associated Factors among Women Attending Delivery Service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital Southwest 2018 Ethiopia.
4.Eva Mautner, et al. The impact of resilience on psychological outcomes in women after pre eclampsia: an observational cohort study, Biomed Central Ind 2013;11(194):1-6.Available from:http://www.hqlo.com/content/11/1/194.
5.BR bansode, Managing Hypertension in pregnancy, Medicine Update 2012 vol.22(3:8); 150-156.
6.Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.Best Pract Res Clin Obstet Gynaecol2011:25(4):391-403. [DOI] [PubMed][Google Scholar].
7.Data on Selected pregnancy complications the United States.Center for Disease Control a Prevention: Center for Disease Control and Prevention: 2019. [Google Scholar].
8.Kuklina EV, Ayala C, Callaghan WM.Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009;113(6): 1299-306. [DOI] [PubMed] [Google Scholar].
9.Steepers, EA, von Dadelszen, P. Duvekot, JJ. and Pijnenborg, R. (2010). Pre-eclampsia. Lancet. 376(9741):631-644.
10.Amir, A., Yunus, M. and Islam, H.M. (1998). Clinico-epidemiological study of factors associated with pregnancy induced hypertension. UCM, 23(1):25-9.
11.Preeclampsia symptoms-mayoclinic; Date of first publication:July 3, 2014 Available from: http://www.mayoclinic.org/…/preeclampsia
12.Brown, M.A., Mackenzie, C., Dunsmuir, W., Roberts, L., Ikin, K., Matthews,J., et al., (2007). Can we predict recurrence of pre-eclampsia or gestational hypertension? BJOG, 114(8):984-993.
13.Anumba, D.O., Lincoln, K. and Robson, S.C. (2010). Predictive value of clinical and laboratory indices as first assessment in women referred with suspected gestational hypertension. Hypertens Pregnancy, 29(2):163-179.
14.Peacock, AS. and Bogossian, F. (2010). Antenatal screening and predicting hypertension in pregnancy for midwives. Women Birth, 23(3):81-93.
15.Ebeigbe, P.N. and Gharoro, EP. (2004). A raised mid-trimester mees arterial blood pressure is it predictive of pregnancy induced hypertension in Nigerian women? Niger Postgrad Med 1, 11(4):294-297.
16.Onwudiwe, N., Yu, C.K., Poon, LC. Spiliopoulos, L and Nicolaides, K.H (2008). Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol, 32(7):877-883.
17.Schoenfeld, A., Ziv, I., Tzeci, A. and Ovadia, J. (1985), Roll-over test-errors in interpretation, due to inaccurate blood pressure measurements. Europ J Obstet Gynaec reprod Biol, 19:23-30.
18.Pilalis, A., Souka, A.P., Antsaklis, P., Daskalakis, G., Papantoniou, N., Mesogitis.S. and Antsaklis, A. (2007). Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks gestation Ultrasound Obstet Gynecol, 29(2): 135-140.
19.Nasrin, B., Fatema, N., Jebunnessa, F, Shamim, S., Chowdhury, S.B. and Ali, L (2010. Early pregnancy maternal serum PAPP-A and urinary protein-creatinine ratio as predictive markers of pregnancy induced hypertension. Mymensingh Mod J, 19(2):267-274.
20.Toppozada, M., Darwish, E.A., Osman, Y.F., and Abd-Rabbo, M.S. (1991). Low dose acetyl salicylic acid in severe eclampsia. Int J of Obstet Gynecol, 35:311-317.
21.Meher, S. and Duley, L. (2006). Rest during pregnancy for preventing pre- eclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev, (2): CD005939.
22.Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, 2014 SOGC Hypertension Guideline Committee, 2014 Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: executive Sum-mary. J Obstet Gynaecol Can 36: 575-576.
23.K.D Tripathi, Essentials of Medical Pharmacology, seventh edition (2013), Jaypee brothers medical publishers (p) ltd.Pg. No 566-568.